Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+11.9M
-
Total reported value, excl. options
-
$200M
-
Value change
-
+$124M
-
Put/Call ratio
-
0.24
-
Number of buys
-
48
-
Number of sells
-
-10
-
Price
-
$10.16
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT) as of Q1 2021
70 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 69M outstanding shares and own 28.46% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.19M shares), FRANKLIN RESOURCES INC (2.89M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.52M shares), RA CAPITAL MANAGEMENT, L.P. (1.25M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.18M shares), CITADEL ADVISORS LLC (1.04M shares), VANGUARD GROUP INC (904K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (811K shares), VR Adviser, LLC (700K shares), and JANUS HENDERSON GROUP PLC (673K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.